New Delhi, April 27 (IANS) India’s major drugmaker Sun Pharmaceutical Industries on Monday announced that it will acquire New York-listed Organon & Co in an all-cash deal valued at $11.75 billion, its biggest overseas acquisition to date.Under the agreement, the pharmaceutical firm will acquire 100 per cent of Organon’s outstanding shares at $14 per share, translating into an enterprise valuation of $11.75 billion and an equity value of around $3.99 billion, the company said in an exchan…
Trending
- Alvida: The Last Goodbye Review — A Haunting Farewell That Lingers Long After the Credits
- Elra Kaaleliyatte Kaala Review: A Soulful Ode to Timelessness That Charms Despite Its Flaws
- Sugriva Movie Review (2026): A Gripping Emotional Thriller That Hits Hard
- Licence Review (2026): Masoom Sharma Delivers a Gripping Haryanvi Crime Drama
- Bhagubai (2026) Review: Nirmiti Sawant Shines in This Heartfelt Marathi Village Drama
- Ginny Wedss Sunny 2 Review (2026): A Warm and Relatable Ride Through the Chaos of Arranged Marriage
- Jerax Review (2026): Nagabhushan’s Supernatural Thriller Is a Wildly Entertaining Ride
- Battle (2026) Movie Review — Tamil Rap Drama Finds Its Rhythm in Flashes